Thematische Bibliographien / Therapeutic use

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte
  6. Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Therapeutic use“

Autor: Grafiati
Veröffentlicht am 4. Juni 2021
Zuletzt aktualisiert am 25. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Therapeutic use" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Therapeutic use"

1

Alvarez, Vincent, Jong Woo Lee, Frank W. Drislane, et al. "Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison." Epilepsia 56, no. 8 (2015): 1275–85. https://doi.org/10.1111/epi.13056.

Der volle Inhalt der Quelle
Annotation:
OBJECTIVE: Benzodiazepines (BZD) are recommended as first-line treatment for status epilepticus (SE), with lorazepam (LZP) and midazolam (MDZ) being the most widely used drugs and part of current treatment guidelines. Clonazepam (CLZ) is also utilized in many countries; however, there is no systematic comparison of these agents for treatment of SE to date. METHODS: We identified all patients treated with CLZ, LZP, or MDZ as a first-line agent from a prospectively collected observational cohort of adult patients treated for SE in four tertiary care centers. Relative efficacies of CLZ, LZP, and
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Varsha*, Robin George Shashank D. "Saroglitazar's Therapeutic Use in Metabolic Syndrome and Nafld." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3200–3207. https://doi.org/10.5281/zenodo.15111106.

Der volle Inhalt der Quelle
Annotation:
Background: Saroglitazar is a novel anti-diabetic drug with combined PPAR-α/-γ agonistic activity. It was developed domestically by an Indian company called Zydus Cadila in 2001, and after numerous preclinical and clinical trials, it received regulatory approval from the Indian drug controller and regulatory authority called DCGI, India in June 2013. Non-alcoholic Fatty Liver Disease, diabetes, obesity, dyslipidemia, and cardiovascular disease are all grouped together as metabolic syndrome, and these conditions are caused by a sedentary and western lifestyle. Type 2 diabetes mellit
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Dvorak, J. "Therapeutic use exemption." British Journal of Sports Medicine 40, Supplement 1 (2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince, and J. E. Bowen. "THERAPEUTIC MODALITY USE." Medicine & Science in Sports & Exercise 33, no. 5 (2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Neekhra, Sachin, Himani Awasthi, and DCP Singh. "Potential Therapeutic use of Streblus asper: A Review." International Journal of Research and Development in Pharmacy & Life Sciences 6, no. 7 (2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Pradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo, and Aristidis Veves. "Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions." US Endocrinology 00, no. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Alvarez, Vincent, Jean-Marie Januel, Bernard Burnand, and Andrea O. Rossetti. "Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam." Epilepsia 52, no. 7 (2011): 1292–96. https://doi.org/10.1111/j.1528-1167.2011.03056.x.

Der volle Inhalt der Quelle
Annotation:
PURPOSE: Phenytoin (PHT), valproic acid (VPA), or levetiracetam (LEV) are commonly used as second-line treatment of status epilepticus (SE), but comparative studies are not available. METHODS: Among 279 adult SE episodes identified prospectively in our tertiary care hospital over 4 years, we retrospectively identified 187 episodes in which PHT, VPA, or LEV were given after benzodiazepines. Patients with postanoxic SE were not included. Demographics, clinical SE features, failure of second-line treatment to control SE, new handicap, and mortality at hospital discharge were assessed. Uni- and mu
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Gallagher, Lisa M., and Francois Bethoux. "Therapeutic use of the Arts for Patients with Multiple Sclerosis." US Endocrinology 13, no. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.

Der volle Inhalt der Quelle
Annotation:
People with multiple sclerosis (MS) face a wide variety of physical, emotional, and social challenges. A multidisciplinary comprehensive care approach is recommended for the management of MS and its consequences, and non-traditional treatments are increasingly considered by patients and health care providers, particularly for the promotion of wellness in the context of this chronic disease. Previous research has demonstrated the benefits of the therapeutic arts (art therapy, dance and movement therapy, and music therapy) in addressing some of the physiological, psychological, cognitive, social
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Groeneweg, Stefan, Robin P. Peeters, Theo J. Visser, and W. Edward Visser. "Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome." US Endocrinology 12, no. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.

Der volle Inhalt der Quelle
Annotation:
Thyroid hormone (TH) is important for normal brain development. The TH transporter protein monocarboxylate transporter 8 (MCT8) is crucial to maintain adequate TH levels in the brain during development and throughout life. Mutations in MCT8 result in the Allan–Herndon–Dudley syndrome (AHDS), which is characterized by a severe delay in neurocognitive development, combined with abnormal serum thyroid function tests (TFTs). The combination of an increased (F)T3 and decreased (F)T4 and rT3 serum levels are characteristic for the presence of AHDS in male patients with moderate to severe delay in ne
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Kundu, Piyali, Taiyeba Tahira, and P. B Kar Mahapatra. "Multidimensional Therapeutic Use of 'Talisadichurna': An Ayurvedic Literary Review." International Journal of Science and Research (IJSR) 11, no. 6 (2022): 82–85. http://dx.doi.org/10.21275/sr22527162152.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Dissertationen zum Thema "Therapeutic use"

1

Xiang, Hong. "Effects of myo-inositol and, or triiodothyronine (T₃) treatment on cardiac dysfunction and elevated myocardial lipid levels in STZ-diabetic rats." Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26675.

Der volle Inhalt der Quelle
Annotation:
A number of experimental studies have implied a link between diabetes-induced lipid accumulation in the myocardium and the development of cardiomyopathy. Since diabetics excrete large amounts of myo-inositol which is a lipotropic agent, this study was undertaken to investigate the effects of myo-inositol on the elevated myocardial lipid levels and the depressed cardiac performance of diabetic rats. Diabetes was induced in female Wistar rats (190-215 g) with streptozotocin (STZ) (55 mg/kg, i.v.). Three days after diabetes induction, myo-inositol was administered in the drinking water (2.5 g/kg/
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Ramez-Baydoun, Lubna Lulu. "Novel chelating agents for therapeutic use." Thesis, King's College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.406043.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Marnewick, Jeanine Lucasta. "Cancer modulating properties of unique South African herbal teas (rooibos and honeybush) in short term in vitro and in vivo carcinogenesis assays." Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/21888.

Der volle Inhalt der Quelle
Annotation:
Dissertation (PhD)--University of Stellenbosch, 2004.<br>ENGLISH ABSTRACT: This thesis provides the first scientific evidence on the cancer modulating properties of two unique South African herbal teas, rooibos (Aspalathus Iinearis) and honeybush (Cyclopia intermedia) utilizing in vitro as well as in vivo carcinogenesis assays by: • Demonstrating the in vitro antimutagenic activity of aqueous extracts of the herbal teas against the metabolic activated mutagens, 2-acetylaminofluorene (2- AAF) and the mycotoxin, aflatoxin B1 (AFB,) as well as, to a certain extent, against the direct acting
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Cheng, Ka-wing, and 鄭家榮. "Preventive potential and mechanism of dietary phenolics on the formation of mutagenic heterocyclic amines." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B4284177X.

Der volle Inhalt der Quelle
Annotation:
The Best PhD Thesis in the Faculties of Dentistry, Engineering, Medicine and Science (University of Hong Kong), Li Ka Shing Prize,2008-2009<br>published_or_final_version<br>Biological Sciences<br>Doctoral<br>Doctor of Philosophy
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Stapleton, Graham Neil. "A study of the effects of sucralfate in the bile duct litigated pig peptic ulcer model with particular reference to the effects on the physico-chemical properties of gastric mucus and including comparisons with famotidine and misoprostol." Master's thesis, University of Cape Town, 1992. http://hdl.handle.net/11427/25727.

Der volle Inhalt der Quelle
Annotation:
Sucralfate is a drug that effectively heals duodenal, gastric and oesophageal ulcers. It is not absorbed systemically and it has been shown to act locally by coating the ulcer base. However when it was also shown to prevent stress ulcers and ethanolinduced gastric mucosa! lesions, it seemed likely that it acted in some way to improve the effectiveness of the gastric mucosa! barrier. Some investigators suggested that it did so by stimulating local prostaglandin release. The Slomiany group, on the basis of in vitro work on the effects of Sucralfate on pig gastric mucus, claimed that Sucralfate a
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Betz, Jennifer. "The Use of Improvisation in Therapeutic Practices." Kent State University Honors College / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ksuhonors1557312650223249.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Parsons, Ann Bernardene. "Designing a resource guide for horticultural therapy programs at botanical gardens and arboreta." Thesis, Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/104531.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

余詩德 and Sze-tak Yu. "Effects of Chinese green tea and tea catechins on lipolysis." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1999. http://hub.hku.hk/bib/B31969677.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Zhang, Jingjing, and 张晶晶. "The anti-cancer properties of cyclometalated gold(III) complexes and organogold(III) supramolecular polymers." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/208171.

Der volle Inhalt der Quelle
Annotation:
Prompted by the successful clinical application of cisplatin in cancer therapy, worldwide efforts have been devoted to develop new metal-based drugs for anticancer treatment. Gold(III) complexes at first received attention as anti-cancer drug candidates because of their square-planar geometry which resembles that of platinum(II) complexes. Subsequent studies revealed that various gold(III) complexes displayed promising anti-cancer activities with different biological mechanisms. Although some achievements have been obtained in the development of anti-cancer gold(III) complexes, challenges incl
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Roberts, Jacintha. "Studies on bisphosphonate elution from orthopaedic implants." Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112582.

Der volle Inhalt der Quelle
Annotation:
In a 6-week rat model it was demonstrated that a small dose of peri-implant zoledronic acid (ZA) increased local bone formation 3-fold compared with controls. Ancillary in vitro studies using 14C-labeled ZA implant doses demonstrated biphasic elution profiles for implants coated with hydroxyapatite; complete ZA release occurred within one to three weeks in serum compared with only 60% ZA release after 12 weeks in water. Implants without hydroxyapatite coating showed more burst-type release profiles and full ZA elution within 24 hours of hydration in serum or water. Canine studies at 6 weeks us
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Bücher zum Thema "Therapeutic use"

1

Jens, Kurreck, ed. Therapeutic oligonucleotides. RSC Pub., 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Raphael, Mechoulam, ed. Cannabinoids as therapeutic agents. CRC Press, 1986.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Tekinay, Ayse B., and Mustafa Ö. Güler. Therapeutic nanomaterials. John Wiley & Sons, Inc., 2016.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Labate, Beatriz Caiuby, and Clancy Cavnar, eds. The Therapeutic Use of Ayahuasca. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-40426-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Wosket, Val. The Therapeutic Use of Self. Routledge, 2016. http://dx.doi.org/10.4324/9780203772263.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Mackway-Girardi, AnnMarie. Therapeutic use of interleukin-2. U.S. DHHS, PHS, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

M, Sondel Paul, and International Cancer Research Data Bank., eds. Therapeutic use of interleukin-2. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Nath, Dwivedi Kedar, ed. The therapeutic use of stories. Routledge, 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Yuti, Chernajovsky, and Nissim Ahuva, eds. Therapeutic antibodies. Springer, 2007.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Béla, Scheiber, and Selby Carla, eds. Therapeutic touch. Prometheus Books, 2000.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "Therapeutic use"

1

Read, Daniel, James Skinner, Daniel Lock, and Aaron CT Smith. "Therapeutic use exemptions." In WADA, the World Anti-Doping Agency. Routledge, 2021. http://dx.doi.org/10.4324/9781003084297-6-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Selekman, Matthew D. "Therapeutic Brick Walls." In The Therapist’s Use of Self. Routledge, 2023. http://dx.doi.org/10.4324/9781003334460-5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Froehlich, Jan. "Therapeutic Use of Self." In Occupational Therapy Essentials for Clinical Competence, 3rd ed. Routledge, 2024. http://dx.doi.org/10.4324/9781003525295-12.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Polatajko, Helene J., Jane A. Davis, and Sara E. McEwen. "Therapeutic Use of Self." In Occupational Therapy, 4th ed. Routledge, 2024. http://dx.doi.org/10.4324/9781003522997-7.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Wiltenburg, Victor Distefano, Dianne da Rocha Prado, and Fúlvio Rieli Mendes. "Therapeutic Use of Hallucinogens." In Drugs and Human Behavior. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62855-0_35.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Lanzotti, Virginia. "Diterpenes for Therapeutic Use." In Natural Products. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-22144-6_192.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Aranki, S. F., F. Mannting, S. K. Shernan, N. C. Cummings, S. P. Sears, and L. H. Cohn. "Transmyocardial Laser Use for Endstage Coronary Artery Disease." In Therapeutic Angiogenesis. Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-03776-8_9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Chugh, Atul R., Samir N. Patel, Venkataraman Rajaram, et al. "The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis." In Therapeutic Lipidology. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_18.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Torres-Gómez, Mariano. "Human Medicinal Mushroom Use." In Therapeutic Mushrooms for Diabetes Mellitus. Apple Academic Press, 2023. http://dx.doi.org/10.1201/9781003332046-3.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Bartolomei, Mirco, and Giovanni Paganelli. "Intracavitary Use of Radionuclides and Treatment of Meningiomas." In Therapeutic Nuclear Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/174_2012_693.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Therapeutic use"

1

Azmeraw, Emiyamrew, Abebe Tesfahun, Tsegazewold Kinfu, Tenagne Fikirie, and Kindu Tigabu. "Deep Learning Approach for Medicinal Plant Identification and Therapeutic Use Prediction." In 2024 International Conference on Information and Communication Technology for Development for Africa (ICT4DA). IEEE, 2024. https://doi.org/10.1109/ict4da62874.2024.10777146.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Hubel, Allison, and Jeffrey McCullough. "Cryopreservation of Cultured Blood Cells for Use in Gene Therapy and Immunotherapy." In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-1318.

Der volle Inhalt der Quelle
Annotation:
Abstract The freezing characteristics of genetically manipulated lymphocytes and hematopoietic stem cells were studied. The water transport characteristics of stem cells which had been cultured and transduced with a therapeutic gene were different from that of a freshly isolated cells. Changes in the freezing characteristics for genetically transformed lymphocytes were also observed. Specifically, cryopreservation protocols developed for the fresh peripheral blood lymphocytes do not produce comparable survival rates for lymphocytes which have been cultured and transduced. These results indicat
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Fikar, Peter, Florian Güldenpfennig, and Roman Ganhör. "The Use(fulness) of Therapeutic Toys." In DIS '18: Designing Interactive Systems Conference 2018. ACM, 2018. http://dx.doi.org/10.1145/3196709.3196721.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Dahl, Elizabeth. "Towards the use of HIFU, in Conjunction with Surgery, in the Treatment of Malignant Brain Tumors." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205469.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

McLaughlan, James. "The Design And Implementation Of A Passive Cavitation Detection System For Use With Ex Vivo Tissue." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205493.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Baldaque-Silva, F., J. P. Pereira, V. Miroslav, W. Naining, and M. Omae. "Are single use endoscopes suitable for therapeutic endoscopy?" In ESGE Days 2024. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1783510.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Bera, Jean-Christophe, Bruno Gilles, Izella Saletes, Claude Inserra, and Hiva Shamsborhan. "Numerical study of cavitation threshold by use of bifrequency excitation." In 11TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2012. http://dx.doi.org/10.1063/1.4757304.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Payne, A., A. Blankespoor, N. Todd, et al. "Optimization of HIFU Treatments for Use in Model Predictive Control." In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131406.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Kaneko, Yukio. "The Design Of Microbubbles Specialized For Therapeutic Or Diagnostic Use." In 4TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2005. http://dx.doi.org/10.1063/1.1901643.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Wong, Serena H., Ronald D. Watkins, Mario Kupnik, Kim Butts Pauly, B. T. Khuri-Yakub, and Emad S. Ebbini. "Progress in Development of HIFU CMUTs for use under MR-guidance." In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131441.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Therapeutic use"

1

Evans, Holly. The Use of Filariae as a Therapeutic Agent for Hypersensitivity Diseases. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ad1012825.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Lillo, Antonietta. Harnessing in vitro evolution to discover antibodies for therapeutic and diagnostic use. Office of Scientific and Technical Information (OSTI), 2021. http://dx.doi.org/10.2172/1773320.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Baldi, Emilio. The Use of Extremely Low Frequencies (ELF) in Pulsed Form (PELF) for Therapeutic Use: A Pilot Study. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada409410.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Templeton, Charles B., Mark A. Poli, and Rikki Solow. Prophylactic and Therapeutic Use of an Anti-Brevetoxin (PbTx-2) Antibody in Conscious Rats. Defense Technical Information Center, 1988. http://dx.doi.org/10.21236/ada210932.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

O'Keefe, Denise S., and Warren D. Heston. Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies Against Prostate Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407353.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling With Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada529400.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada568442.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada554188.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

King, Ebony. Plain Language Summary: Naltrexone Utilization Along its Dosing Spectrum - a Literature Review. WritePharma, 2025. https://doi.org/10.70390/cwc0auh7n.

Der volle Inhalt der Quelle
Annotation:
Naltrexone, a widely recognized opioid receptor antagonist, has been primarily used at standard doses of 50–100 mg daily to treat opioid and alcohol use disorders. Recent studies, however, reveal its versatility across a broader dosing spectrum. This review examines the therapeutic effects and safety profiles of naltrexone across three dosing strategies: standard doses for substance use disorders, low-dose naltrexone (LDN, 1–5 mg/day) for chronic pain and autoimmune diseases, and ultra-low-dose naltrexone (ULDN, microgram levels) as a complement to opioid therapy. However, naltrexone’s role in
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Sentcоv, Valentin, Andrei Reutov, and Vyacheslav Kuzmin. Electronic training manual "Acute drug poisoning". SIB-Expertise, 2024. http://dx.doi.org/10.12731/er0776.29012024.

Der volle Inhalt der Quelle
Annotation:
The widespread use in modern medicine of hypnotics, sedatives, tricyclic antidepressants, antihypertensive drugs and antipyretics, even in therapeutic dosages, sometimes leads to adverse consequences for the patient. Accidental or intentional excess of therapeutic dosages leads to severe poisoning. This fact indicates the high relevance of doctors’ knowledge of any clinical specialty and the treatment of poisoning by these groups of drugs. This electronic educational resourse consists of six theoretical educational modules: poisoning with barbituric acid derivatives, acute poisoning with tricy
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Therapeutic use" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen Bücher
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie